Paradoxical antitumor effects of pazopanib in a cutaneous angiosarcoma patient

J Dermatol. 2017 Sep;44(9):1078-1079. doi: 10.1111/1346-8138.13636. Epub 2016 Oct 11.

Authors

Toshihiko Hoashi^{1

2}, Megumi Hirabayashi², Rina Nakajima², Naomi Takahashi², Hidehisa Saeki¹

Affiliations

¹ Department of Dermatology, Nippon Medical School, Tokyo, Japan.
² Department of Dermatology, Sanraku Hospital, Tokyo, Japan.

PMID: 27726177
DOI: 10.1111/1346-8138.13636

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Angiogenesis Inhibitors / adverse effects*
Disease Progression
Head and Neck Neoplasms / drug therapy*
Head and Neck Neoplasms / pathology
Hemangiosarcoma / drug therapy*
Hemangiosarcoma / pathology
Humans
Indazoles
Male
Pyrimidines / adverse effects*
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Sulfonamides / adverse effects*

Substances

Angiogenesis Inhibitors
Indazoles
Pyrimidines
Sulfonamides
pazopanib